Structure-Activity Relationship Study Reveals Benzazepine Derivatives of Luteolin as New Aldose Reductase Inhibitors for Diabetic Cataract

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|13|3|152-163

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.13, Iss.3, 2016-10, pp. : 152-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quantitative Structure-Activity Relationship Study of Aromatic Inhibitors Against Rat Lens Aldose Reductase Activity Using Variable Selections

By  

Medicinal Chemistry, Vol. 9, Iss. 3, 2013-05 ,pp. : 410-419

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and activity of a new series of chalcones as aldose reductase inhibitors

By Severi F.   Benvenuti S.   Costantino L.   Vampa G.   Melegari M.   Antolini L.  

European Journal of Medicinal Chemistry, Vol. 33, Iss. 11, 1998-11 ,pp. : 859-866

Elsevier

Access to resources Recommend Favorite

Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 373-385

Bentham Science Publishers

Access to resources Recommend Favorite

Aldose reductase inhibitors: therapeutic implications for diabetic complications

By Oates P.J.   Mylari B.L.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2095-2119

Informa Healthcare

Access to resources Recommend Favorite

Aldose Reductase Inhibitors and Nanodelivery of Diabetic Therapeutics

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 4, 2012-04 ,pp. : 326-336

Bentham Science Publishers

Access to resources Recommend Favorite